Surgical Science Sweden AB (SUSRF) Stock Price, Trades & News

Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.

Financial Strength

10/10

Name	Current	Vs Industry
Cash-To-Debt	311.15
Equity-to-Asset	0.92
Debt-to-EBITDA	0.03
Interest Coverage	54.65
Piotroski F-Score	7/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	3.18	Distress Grey Safe
Beneish M-Score	-2.54	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	7.3
	3-Year EBITDA Growth Rate	-10.2
	3-Year EPS without NRI Growth Rate	-29.2
	3-Year FCF Growth Rate	-31.6
	3-Year Book Growth Rate	0.1
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	38.75
	Future 3-5Y Total Revenue Growth Rate Estimate	7.93

Momentum Rank

4/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	89.89
	9-Day RSI	91.63
	14-Day RSI	91.96
	3-1 Month Momentum %	40.85
	6-1 Month Momentum %	10.19
	12-1 Month Momentum %	-73.51

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	4.44
	Quick Ratio	3.66
	Cash Ratio	2.5
	Days Inventory	219.25
	Days Sales Outstanding	49.58
	Days Payable	51.27

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-0.1
	Shareholder Yield %	0.86

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	65.5
	Operating Margin %	6.95
	Net Margin %	5.34
	EBITDA Margin %	6.95
	FCF Margin %	9.64
	OCF Margin %	15.43
	ROE %	1.2
	ROA %	1.1
	ROIC %	1.14
	3-Year ROIIC %	68.48
	ROC (Joel Greenblatt) %	36.86
	ROCE %	1.51
	Years of Profitability over Past 10-Year	8
	Moat Score	6
	Tariff Resilience Score	7

GF Value Rank

2/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	30.64
	Forward PE Ratio	17.54
	PE Ratio without NRI	30.64
	Shiller PE Ratio	19.86
	Price-to-Owner-Earnings	69.67
	PEG Ratio	1.15
	PS Ratio	1.65
	PB Ratio	0.36
	Price-to-Tangible-Book	1.72
	Price-to-Free-Cash-Flow	17.24
	Price-to-Operating-Cash-Flow	10.73
	EV-to-EBIT	13.92
	EV-to-Forward-EBIT	6.85
	EV-to-EBITDA	13.92
	EV-to-Forward-EBITDA	4.32
	EV-to-Revenue	0.97
	EV-to-Forward-Revenue	0.93
	EV-to-FCF	10.11
	Price-to-GF-Value	0.21
	Price-to-Projected-FCF	0.34
	Price-to-DCF (Earnings Based)	0.96
	Price-to-DCF (FCF Based)	0.62
	Price-to-Peter-Lynch-Fair-Value	2.61
	Price-to-Graham-Number	1.53
	Price-to-Net-Current-Asset-Value	2.02
	Price-to-Net-Cash	5.8
	Earnings Yield (Greenblatt) %	7.18
	FCF Yield %	5.8
	Forward Rate of Return (Yacktman) %	17.47

GF Value™: $19.33

SUSRF

Warning Signs

Warning! GuruFocus detected 2 Severe warning signs with SUSRF. Try a 7-Day Free Trial to check it out.

Surgical Science Sweden AB Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Surgical Science Sweden AB Stock Events

Financials Calendars

Event	Date	Price ($)
Third quarter earnings conference call for 2026	2026-11-12	In 137 days
Third quarter earnings results for 2026	2026-11-12	In 137 days
Second quarter earnings conference call for 2026	2026-08-19	In 52 days
Second quarter earnings results for 2026	2026-08-19	In 52 days
General meeting for 2026	2026-05-21 15:00	4.09 (+3.54%)
First quarter earnings conference call for 2026	2026-05-20 11:00	2.84 (+0.00%)
First quarter earnings results for 2026	2026-05-20 07:30	2.84 (+0.00%)
Annual report for 2025	2026-04-15	2.84 (+0.00%)
Fourth quarter earnings conference call for 2025	2026-02-19 11:00	2.84 (+0.00%)
Fourth quarter earnings results for 2025	2026-02-19 07:30	2.84 (+0.00%)

Show

Entries

Guru Commentaries on OTCPK:SUSRF

No articles.

Press Release

	Subject	Date
No Press Release

Articles on Surgical Science Sweden AB

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.